Development of Magnetic Particle–Based Chemiluminescence Immunoassays for Detecting PCV2 VLP‐ and Rep‐Specific Antibodies and Their Combined Use for Immune Evaluation and Replication‐Associated Exposure Assessment

Transboundary and Emerging Diseases · Published 2026-01-01 · DOI 10.1155/tbed/3733817

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1155/tbed/3733817

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles